vaso-occlusive crisis.Whether zinc loss can be reduced by prevention of recurrent ischemia or the use of bisphosphonates should be studied in a prospective clinical trial.Life-long urinary wasting of zinc in SCD may justify supplementation of zinc in sickle cell patients.
No takes yet. Share an insight, caveat, or question.
Gustine et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: